ArticleScience progress
Clinical characteristics and outcomes of Chlamydia psittaci pneumonia: Insights from targeted next-generation sequencing diagnosis.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe aim is to enhance clinician awareness of the disease, reduce the risk of misdiagnosis, and analyze the risk factors for the progression of Chlamydia psittaci infection to severe pneumonia.MethodsWe conducted a retrospective analysis of the clinical data from patients infected with Chlamydia psittaci at our hospital.ResultsThirty-three patients diagnosed with Chlamydia psittaci pneumonia were included in this study. Among them, 23 (72.2%) were male and 10 (27.8%) were female, with a mean age of 59.1 ± 11.1 years. Twenty-four patients (72.7%) had a clear history of poultry exposure. The main clinical manifestations were high fever (n = 30, 90.9%), cough (n = 28, 84.8%), chill (n = 24, 72.7%), expectoration (n = 22, 66.7%), fatigue (n = 20, 60.6%), poor appetite (n = 20, 60.6%), dyspnea (n = 13, 39.4%), and myalgia (n = 10, 30.3%). The lymphocyte count in severe pneumonia group was significantly lower than that in non-severe pneumonia group. C-reactive protein, erythrocyte sedimentation rate, and lactate dehydrogenase levels in the severe group were remarkably higher than those in the non-severe group. The common imaging findings included flake high-density shadows (n = 29, 87.9%), consolidation (n = 20, 60.6%), pleural effusion (n = 17, 51.5%), bronchial inflation signs (n = 15, 45.5%), and ground-glass exudation (n = 20, 60.6%). The majority of patients received treatment with either doxycycline alone, quinolones alone, or a combination of doxycycline and quinolones.ConclusionHistory of contact with birds or poultry, repeated high fever, and flake high-density shadows with consolidation in Chest computed tomography can serve as important indicators for diagnosing C. psittaci pneumonia. Lower lymphocyte counts were identified as the sole risk factor associated with severe C. psittaci pneumonia. Quinolones and doxycycline are effective treatments for C. psittaci pneumonia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.